BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bolton Medical Obtains CE Mark for New Relay NBS With Plus Delivery System


4/6/2010 10:25:58 AM

SUNRISE, FL--(Marketwire - April 06, 2010) - Bolton Medical announced today that it has obtained a CE Mark for its newly improved Relay NBS (Non-Bare Stent) Thoracic Stent-Graft with Plus Delivery System. The new system allows for improved covered-graft apposition in tightly curved aortas and greater expansion control in larger diameter anatomies during the treatment of complex thoracic aortic aneurysms.

When a covered (or non-bare) stent is used in a tightly curved aorta, it can cause a gap or 'bird beak' in which the proximal end of the stent fails to lay flat against the inner curvature of the aortic arch, increasing the incidence of endoleaks and graft complications. Additionally, in larger diameter anatomies, the graft may 'retroflex' or in-fold toward its inner curvature during deployment. The Relay NBS Thoracic Stent-Graft with Plus Delivery System has incorporated key design changes to reduce the potential for both these complications.

The Relay NBS Thoracic Stent-Graft with Plus Delivery System was CE marked in March 2010 and will be available in Europe and all countries that recognize CE mark certification. It will be launched at the International Charing Cross Annual Symposium in London at Bolton Medical Symposium on Monday, April 12, 2010 from 12:30-1:30pm.

The Relay NBS Thoracic Stent-Graft with Plus Delivery System represents the latest innovation for the Relay aortic product line and is part of Bolton Medical's ongoing commitment to develop the highest quality, most innovative technologies for aortic repair.

Relay and Relay NBS Endovascular Stent-Grafts are indicated for the treatment of main thoracic aortic pathologies such as aneurysms, penetrating ulcers, pseudoaneurysms and intramural hematomas in adult patients. As of today, more than 3000 patients have been treated world-wide with Relay and Relay NBS Stent-Grafts.

COMPANY

Bolton Medical is a private company, with European operations based in Barcelona, Spain, and U.S. operations in Sunrise, Florida. Bolton Medical is a wholly-owned subsidiary of the Werfen Life Group, a diverse manufacturer and supplier of products for the medical industry.
www.boltonmedical.com


Public Relations Contacts:
USA: Candace DeLeonardis 1-954-636-9785
EU and other countries: Carlos Camps + 34 93.817.63.10



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES